Market Place
Sourcing Support
Sumitomo Pharma tidies up 7 units into 1 combined U.S. entity
03 Apr 2023 //
FIERCE BIOTECH
Sumitovant subsidiaries Enzyvant and Altavant merge into combined company
06 Dec 2022 //
ENDPTS
Another new manufacturing site for NC; BioCentriq acquired by South Korean
22 Apr 2022 //
ENDPTS
Enzyvant Announces Plans to Expand Regenerative Medicine Manufacturing
21 Apr 2022 //
GLOBENEWSWIRE
Enzyvant’s Path From CRL To FDA Approval For CMC Revamp
12 Jan 2022 //
PHARMAINTELLIGENCE
FDA approves Enzyvant`s regenerative tissue-based therapy
11 Oct 2021 //
SEEKING ALPHA
FDA approves Enzyvant’s Rethymic, for pediatric congenital athymia
11 Oct 2021 //
PHARMABIZ
Enzyvant Receives FDA Approval for RETHYMIC®
08 Oct 2021 //
GLOBENEWSWIRE
FDA mistakingly awards priority review to Enzyvant`s regenerative therapy
02 Oct 2021 //
ENDPTS
Enzyvant Announces Data on Burden of Illness & Costs of Supportive Care for PCA
26 Aug 2021 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.